Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design

BACKGROUND: Among patients with rectal cancer, 5–10 % have a primary rectal cancer beyond the total mesorectal excision plane (PRC-bTME) and 10 % recur locally following primary surgery (LRRC). In both cases, patients ‘care remains challenging with a significant worldwide variation in practice regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Denost, Quentin, Saillour, Florence, Masya, Lindy, Martinaud, Helene Maillou, Guillon, Stephanie, Kret, Marion, Rullier, Eric, Quintard, Bruno, Solomon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820920/
https://www.ncbi.nlm.nih.gov/pubmed/27044252
http://dx.doi.org/10.1186/s12885-016-2286-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820920/
https://www.ncbi.nlm.nih.gov/pubmed/27044252
http://dx.doi.org/10.1186/s12885-016-2286-1

Ejemplares similares